Binge eating treatment is tasty for Shire
Wednesday 06 November 2013
News that its binge eating disorder treatment has passed clinical trials sent shares in Shire soaring to an intraday high yesterday.
The amphetamine-based drug Vyvanse is already used to treat American students with ADHD but has now been shown to be effective in cutting the number of days per week when people with eating disorders feel the need to binge.
"We are extremely pleased with these results," said chief executive Flemming Ornskov.
"Binge Eating Disorder is a condition for which there is no currently approved pharma-cologic treatment and yet there is significant unmet patient need, as was demonstrated with the faster-than-expected enrolment of participants in our clinical trial programme."
Shares in Shire surged to a record 2,892p in early trade before settling at 2,858p, up 38p. The company said the trials were completed earlier than expected and it would now seek approval from US regulators to use Vyvanse to treat BED.
Newcastle winger reveals he has testicular cancer - and is losing his trademark long hair as a result
Actors star in Woody Allen's 'Magic in the Moonlight'
Human faces unique 'because we don't recognise each other by smell'
Man's attempt to avoid being impounded heavily criticised
- 1 Scottish independence: Ireland since 1919 is a lesson for Scotland in what a Yes vote means
- 2 A bottle of wine a day is not bad for you and abstaining is worse than drinking, scientist claims
- 3 Say yes to 'no-poo': It's been three years since I stopped washing my hair
- 4 Grandmas keep accidentally tagging themselves as Grandmaster Flash on Facebook
Sports Direct security guard allegedly banned Jewish schoolboys and told them: 'No Jews, no Jews'
Jennifer Lawrence and Kate Upton nude pictures exhibition cancelled after artist concedes photos were 'stolen property'
Scottish independence referendum: A nation divided against itself
John Travolta addresses former pilot's gay romance allegations publicly for the first time: 'That was the lowest I'd ever felt'
Richard III: Two years after his body was found scientists discover how he died
iJobs Money & Business
£18000 - £23000 per annum + Commission: SThree: Real Staffing are currently lo...
£20000 - £25000 per annum + OTE £35,000 first year: SThree: The SThree group i...
£20 - 24k (Uncapped Commission - £35k Year 1 OTE): Guru Careers: We are seekin...
£20 - 24k + Benefits: Guru Careers: This is a great opportunity for an enthusi...